Results 21 to 30 of about 4,938,261 (300)

Disseminated tuberculosis with myelofibrosis presentation: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Primary myelofibrosis is a rare myeloproliferative disorder in middle-aged and old adults and should be distinguished from secondary and reactive causes of bone marrow fibrosis because, in reactive fibrosis, treatment approaches depend on the ...
Mahdi Khatuni   +3 more
doaj   +1 more source

Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity

open access: yesFrontiers in Pediatrics, 2022
Myelofibrosis is a rare myeloproliferative disorder. The detailed descriptions of myelofibrosis in children and adolescents is limited to a few case series and case reports describing fewer than 100 patients, thus suggesting the extreme rarity of this ...
Fabiola Guerra   +12 more
doaj   +1 more source

Correlation between Primary Myelofibrosis and the Association of Portal Thrombosis with Portal-Biliary Cavernoma: US, MDCT, and MRI Features

open access: yesJournal of Gastrointestinal and Abdominal Radiology, 2021
Objective Myelofibrosis is a rare chronic myelolymphoproliferative disease and is associated with increased risk of venous thromboembolism. The objective of this study is to retrospectively evaluate patients with primary myelofibrosis who underwent ...
Marco Di Girolamo   +5 more
doaj   +1 more source

Treatment of primary myelofibrosis

open access: yesTurkish Journal of Hematology, 2009
Şinasi Özsoylu
doaj   +2 more sources

Fatal Disseminated Tuberculosis and Concurrent Disseminated Cryptococcosis in a Ruxolitinib-treated Patient with Primary Myelofibrosis: A Case Report and Literature Review

open access: yesInternal medicine, 2021
Ruxolitinib, a Janus kinase inhibitor, improves symptoms in patients with myelofibrosis. However, its association with the development of opportunistic infections has been a concern.
Asuka Ogai   +5 more
semanticscholar   +1 more source

Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis. [PDF]

open access: yesAm J Hematol, 2023
Mechanisms through which mature megakaryocytes (Mks) and their progenitors sense the bone marrow extracellular matrix to promote lineage differentiation in health and disease are still partially understood.
Abbonante V   +15 more
europepmc   +2 more sources

Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management

open access: yesAmerican journal of hematology/oncology, 2020
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell‐derived clonal myeloproliferation that is often but not always accompanied by JAK2, CALR, or MPL mutations.
A. Tefferi
semanticscholar   +1 more source

Focus on Osteosclerotic Progression in Primary Myelofibrosis

open access: yesBiomolecules, 2021
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by hematopoietic stem-cell-derived clonal proliferation, leading to bone marrow (BM) fibrosis.
M. Spampinato   +14 more
semanticscholar   +1 more source

A patient with a germline GATA2 mutation and primary myelofibrosis.

open access: yesBlood Advances, 2021
First description of a patient with a germline GATA2 mutation and diagnosis of primary myelofibrosis. Development of bone marrow failure on a Janus kinase inhibitor.
C. Rütsche   +4 more
semanticscholar   +1 more source

Primary myelofibrosis L.

open access: yesОнкогематология, 2014
Literature data of idiopathic myelofibrosis are presented: classification, diagnostic criteria, morphological and molecular features. Particular attention is given to therapy of various clinical forms of primary myelofibrosis.
L. M. Meshcheryakova   +4 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy